AHA offers research funding programs to eligible investigators and institutions across the U.S.
The AHA generally has two funding cycles per year – always check application deadlines. Not all programs are offered in each cycle. Only those listed on this page are available at this time. Carefully review the program descriptions below for eligibility criteria and restrictions.
Applications are created, submitted, and reviewed through our Grants@Heart electronic system.
American Heart Association research awards are limited to non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research. Applications will not be accepted for work with funding to be administered through any federal institution or work to be performed by a federal employee with the exception of (1) applications specifically related to the AHA’s Institute for Precision Cardiovascular Medicine, and (2) the Veterans Administration employees. Funding is prohibited for awards at non-U.S. institutions.
Applications by existing collaborators are permitted, provided that the proposal is for a new idea or new approach that has not been funded before.
Letter of Intent deadline is Thursday, November 3, 2016, 5 pm Central Time. AHA will contact the applicants who have been selected to submit a full application.
This award will support individual scientists with a trajectory of success, who propose novel approaches to major research challenges in the areas of CV and stroke that have the potential to produce unusually high impact.
The required Letter of Intent deadline is Tuesday, November 22, 2016, 5 pm Central Time. AHA will contact the applicants who have been selected to submit a full application.
Institute for Precision Cardiovascular Medicine Awards
Precision cardiovascular medicine takes into account an individual's lifestyle, environment and biology to help identify the underlying causes of cardiovascular related risk factors and events to help decrease and prevent these risk factors and events. This new field of precision medicine utilizes advanced methods of aggregating, integrating and analyzing patient data. Our grant mechanisms will be focused on many aspects of precision cardiovascular medicine to reach our goals.
Please check our Funding Opportunities Page for more information about our grant mechanisms and deadlines.
AHA-Allen Distinguished Investigator Awards
An AHA-Allen Distinguished Investigator is an active researcher who will lead a compass-driven, leadership-guided research program intended to open an area (scientific “compass” direction) at the frontier of cardiovascular research defined by their own vision, listening tours of The Paul G. Allen Frontiers Group, and ongoing AHA dialogues with science advisors. AHA-Allen Distinguished Investigators are pioneers who will expand the frontiers of bioscience. The purpose of this inaugural funding partnership is to discover and fund highly promising investigators working in research on the cardiovascular extracellular matrix (ECM), who have creative ideas with the potential to move ECM science forward and transform matrix biology.
For more information, please visit our AHA-Allen Distinguished Investigator Awards page.
Research AnnouncementsStrategically Focused Research Network News
Institute for Precision Cardiovascular Medicine Funding Announcement
Research Partnership Programs
2015-2016 Research Facts (PDF)
View the latest Research Facts:
2015-2016 Pediatric Research Facts (PDF)
View the latest
AHA Research awardees.
For program questions/inquiries, call 214-360-6107 (option 1) or email firstname.lastname@example.org.